Incyte Corporation
INCY
Jodie situation report
Incyte Corporation's current read is isolated; its market group is not confirming.
The latest filing evidence is available. 0 of 9 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 16 directly disclosed connections are confirming.
- Revenue increased 20.9% versus the comparable filing period.
- Paid demand rose 9% (three months) and 8% (six months) ended June 30, 2026 across indications; monitor future reported year‑over‑year paid demand percentages.
Invalidation: The isolated read changes if INCY's group or a disclosed connection begins moving with it.
Who this business touches
The relationships behind INCY
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
SNDXSyndax Pharmaceuticals, Inc.partnerApr 28, 2026 ▾
“In addition to establishing collaborative or license arrangements under which other parties license our drug candidates for development and commercialization or under which we study our drug candidates in combination with such parties’ compounds or biologics,…”
MGNXFiling-linked namepartnerApr 28, 2026 ▾
“In addition to establishing collaborative or license arrangements under which other parties license our drug candidates for development and commercialization or under which we study our drug candidates in combination with such parties’ compounds or biologics,…”
Depended on by
SNDXSyndax Pharmaceuticals, Inc.partnerApr 30, 2026 ▾
“We are leading the commercialization and further development of revumenib and working closely with our collaboration partner, Incyte, on the commercialization and further development of axatilimab.”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 20 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
INCY is currently a Follower in the organic co-movement group Biotechnology. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.